Cargando…
临床试验不良事件监管在可手术III期非小细胞肺癌新辅助治疗中的作用
BACKGROUND AND OBJECTIVE: Programmed cell death protein 1 (PD-1) combined with platinum containing dual drug chemotherapy is a new adjuvant treatment option for operable stage III non-small cell lung cancer (NSCLC), and the quality assurance of clinical trials of related drugs plays a crucial role i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365963/ https://www.ncbi.nlm.nih.gov/pubmed/37488083 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.23 |